Serum Eosinophilic Cationic Protein Is a Reliable Biomarker for Childhood Asthma

Author:

Rydell Niclas,Nagao Mizuho,Movérare RobertORCID,Ekoff Helena,Sjölander AndersORCID,Borres Magnus P.,Fujisawa Takao

Abstract

<b><i>Background:</i></b> Eosinophilic cationic protein (ECP) is associated with airway inflammation and asthma. However, the clinical value of measuring ECP in childhood asthma is not fully known. We aimed to study the diagnostic performance of serum ECP and other common asthma biomarkers, individually and in combinations. <b><i>Methods:</i></b> In a cross-sectional study, 5–16-year-old children with current asthma (CA) (<i>n</i> = 37), transient asthma (TA) (<i>n</i> = 43), (previous history of wheezing/asthma), and healthy children (HC) (<i>n</i> = 86) were investigated for ECP, blood eosinophil count (B-Eos), fractional exhaled nitric oxide (FeNO), and lung function, i.e., spirometry (forced expiratory volume during the first second [FEV1]/forced vital capacity [FVC] ratio). <b><i>Results:</i></b> Both ECP and B-Eos were higher in CA compared to TA (<i>p</i> &#x3c; 0.01) and HC (<i>p</i> &#x3c; 0.0001). ECP and B-Eos were also higher in TA compared to HC (<i>p</i> &#x3c; 0.05 and <i>p</i> &#x3c; 0.001, respectively). FeNO was higher in CA (<i>p</i> &#x3c; 0.0001) and TA (<i>p</i> &#x3c; 0.01) compared to HC but similar between the asthma groups. The FEV1/FVC ratio was lower in CA compared to TA and HC (both <i>p</i> &#x3c; 0.01) but similar between TA and HC. The best diagnostic performance regarding CA was found for ECP and B-Eos with receiver operating characteristics area under curve (AUC) of 0.801 and 0.810, respectively. The optimal cutoff for ECP (29 μg/L) yielded a sensitivity and specificity of 70.3% and 81.4%. The corresponding AUCs for FeNO and FEV1/FVC were 0.732 and 0.670, respectively. ECP and B-Eos showed the highest AUCs (0.669 and 0.673) for differentiation between CA and TA. Combining ECP with FeNO and FEV1/FVC increased the odds ratio (OR) for having CA from OR 3.97–10.3 for the single biomarkers to OR 20.2 (95% confidence interval: 5.76–68.6). <b><i>Conclusion:</i></b> Our results show that serum ECP is a reliable biomarker in the diagnosis of childhood asthma, with additional value in combination with FeNO and FEV1/FVC, and that ECP can be an alternative to B-Eos.

Publisher

S. Karger AG

Subject

Immunology,General Medicine,Immunology and Allergy

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. The Blood Biomarkers of Asthma;New Perspectives on Asthma;2023-10-11

2. Current Insights on the Impact of Proteomics in Respiratory Allergies;International Journal of Molecular Sciences;2022-05-20

3. Asthma and Allergy: Unravelling a Tangled Relationship with a Focus on New Biomarkers and Treatment;International Journal of Molecular Sciences;2022-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3